Filing Details
Entera Bio Ltd. (NASDAQ:ENTX) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
8k filedNASDAQ:ENTX
Entera Bio Ltd. (ENTX) Reports Material Event to SEC
Entera Bio Ltd. (NASDAQ:ENTX) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
At publication ·
What changed
Entera Bio Ltd. (NASDAQ:ENTX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Entera Bio Ltd. (NASDAQ: ENTX) filed a Form 8-K with the SEC on August 18, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $2.89 with a market capitalization of $101.8 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Entera Bio Ltd.'s stock currently trades at $2.89 with a market capitalization of $101.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Entera Bio Ltd.'s stock.
All SEC filings for Entera Bio Ltd. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ENTX Stock Page
Frequently Asked Questions
Where can I read ENTX's SEC filings?
Browse all filings on our ENTX SEC filings page.
What types of SEC filings does Entera Bio Ltd. file?
Public companies like Entera Bio Ltd. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.